Pancreatic hyperplasia after gastric bypass surgery in a GK rat model of non-obese type 2 diabetes

Journal of Endocrinology

Volumn 228, Issue 1, 2016, Pages 13-23

  Zhou, Xinrong ^a   Qian, Bangguo ^b,c   Ji, Ning ^b,d   Lui, Conghui ^b   Liu, Zhiyuan ^b   Li, Bing ^b   Zhou, Huarong ^b,e,f   Yan, Caifeng ^d  

^a Tongji Hospital   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^e JIANGSU UNIVERSITY   (China)

^f Sherman College of Chiropractic   (United States)

Author keywords

Gastric bypass surgery; Hyperplasia; cell; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DNA CONTENT; EXOCRINE SECRETION; GLYCEMIC CONTROL; GOTO KAKIZAKI RAT; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN RELEASE; INSULIN RESPONSE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS PERFUSION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; STOMACH BYPASS; ANALYSIS; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; DISEASE MODEL; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERPLASIA; INSULIN RESISTANCE; PANCREAS; PATHOLOGY; SECRETION (PROCESS); WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FASTING; GASTRIC BYPASS; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERPLASIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; PANCREAS; RATS; RATS, WISTAR;

EID: 84953269993     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0701     Document Type: Article

References (46)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K 2004 Bariatric surgery: a systematic review and metaanalysis. Journal of the American Medical Association 292 1724-1737. (doi:10.1001/jama.292.14.1724)
2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA&Butler PC 2003 ß-cell deficit and increased ß-cell apoptosis in humans with type 2 diabetes. Diabetes 52 102-110. (doi:10.2337/diabetes.52.1.102)
3. Chen H, Martin B, Cai H, Fiori JL, Egan JM, Siddiqui S&Maudsley S 2013 Pancreas ++: automated quantification of pancreatic islet cells in microscopy images. Frontiers in Physiology 3 482. (doi:10.3389/fphys.2012.00482)
4. Chintinne M, Stangé G, Denys B, In 't Veld P, Hellemans K, Pipeleers-Marichal M, Ling Z&Pipeleers D 2010 Contribution of postnatally formed small ß cell aggregates to functional ß cell mass in adult rat pancreas. Diabetologia 53 2380-2388. (doi:10.1007/s00125-010-1851-4)
5. Cohen D 2013 Hyperplasia from GLP-1 drugs is 'not a surprise,' say researchers. BMJ 346 f2025. (doi:10.1136/bmj.f2025)
6. Dor Y, Brown J, Martinez OI & Melton DA 2004 Adult pancreatic ß-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429 41-46. (doi:10.1038/nature02520)
7. Dutia R, Brakoniecki K, Bunker P, Paultre F, Homel P, Carpentier AC, McGinty J&Laferrère B 2014 Limited recovery of ß-cell function after gastric bypass despite clinical diabetes remission. Diabetes 63 1214-1223. (doi:10.2337/db13-1176)
8. Eickhoff H, Louro T, Matafome P, Seica R&Castro e Sousa F 2014 Glucagon secretion after metabolic surgery in diabetic rodents. Journal of Endocrinology 223 255-265. (doi:10.1530/JOE-14-0445)
9. Haegel P, Stock C, Marescaux J, Petit B&Grenier JF 1981 Hyperplasia of the exocrine pancreas after small bowel resection in the rat. Gut 22 207-212. (doi:10.1136/gut.22.3.207)
10. Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF et al. 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Annals of Surgery 227 637-643. (doi:10.1097/00000658-199805000-00004)
11. Jorgensen NB, Jacobsen SH, Dirksen C, Bojsen-Moller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, indqvist Hansen D et al. 2012 Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. American Journal of Physiology-Endocrinology and Metabolism 303 E122-E131. (doi:10.1152/ajpendo.00073.2012)
12. Kant P, Sainsbury A, Reed KR, Pollard SG, Scott N, Clarke AR, Coletta PL & Hull MA 2011 Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB. Gut 60 893-901. (doi:10.1136/gut.2010.230755)
13. Kara ME 2005 The anatomical study on the rat pancreas and its ducts with emphasis on the surgical approach. Annals of Anatomy 187 105-112. (doi:10.1016/j.aanat.2004.10.004)
14. Khoo CM, Muehlbauer MJ, Stevens RD, Pamuklar Z, Chen J, Newgard CB & Torquati A 2014 Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction. Annals of Surgery 259 687-693. (doi:10.1097/SLA.0b013e318296633f)
15. Lamprianou S, Immonen R, Nabuurs C, Gjinovci A, Vinet L, Montet XC, Gruetter R&Meda P 2011 High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets. Diabetes 60 2853-2860. (doi:10.2337/db11-0726)
16. Li B, Zhou X, Wu J&Zhou H 2013 rom gut changes to type 2 diabetes remission after Gastric Bypass Surgeries. Frontiers of Medicine 7 191-200. (doi:10.1007/s11684-013-0258-2)
17. Lindqvist A, Spégel P, Ekelund M, Garcia Vaz E, Pierzynowski S, Gomez MF, Mulder H, Hedenbro J, Groop L&Wierup N 2014 Gastric bypass improves ß-cell function and increases ß-cell mass in a porcine model. Diabetes 63 1665-1671. (doi:10.2337/db13-0969)
18. Madden SG, Loeb SJ&Smith CA 2008 An integrative literature review of lifestyle interventions for the prevention of type II diabetes mellitus. Journal of Clinical Nursing 17 2243-2256. (doi:10.1111/j.1365-2702.2008.02335.x)
19. Maechler P, Gjinovci A&Wollheim CB 2002 Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas. Diabetes 51 S99-102. (doi:10.2337/diabetes.51.2007.S99)
20. Meier JJ, Butler AE, Galasso R&Butler PC 2006 Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased ß-cell turnover. Diabetes Care 29 1554-1559. (doi:10.2337/dc06-0392)
21. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza RA & Butler PC 2008 ß-cell replication is the primary mechanism subserving the postnatal expansion of ß-cell mass in humans. Diabetes 57 1584-1594. (doi:10.2337/db07-1369)
22. Miyasaka K, Ohta M, Tateishi K, Jimi A&Funakoshi A 1998 Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression. Pancreas 16 114-123. (doi:10.1097/00006676-199803000-00002)
23. Moses A 2013 Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage. BMJ 347 f4386. (doi:10.1136/bmj.f4386)
24. Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K, Skovronsky DM, Herold KC, McCarthy TJ, Calle RA et al. 2012 In vivo imaging of endogenous pancreatic ß-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. Journal of Nuclear Medicine 53 908-916. (doi:10.2967/jnumed.111.100545)
25. Oger-Roussel S, Behr-Roussel D, Caisey S, Kergoat M, Charon C, Audet A, Bernabé J, Alexandre L&Giuliano F 2013 Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 306 R108-R117. (doi:10.1152/ajpregu.00033.2013)
26. Pacheco D, de Luis DA, Romero A, González Sagrado M, Conde R, Izaola O, Aller R&Delgado A 2007 The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. American Journal of Surgery 194 221-224. (doi:10.1016/j.amjsurg.2006.11.015)
27. Patriti A, Aisa MC, Annetti C, Sidoni A, Galli F, Ferri I, Gullà N&Donini A 2007 How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and ß-cell function in Goto-Kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 142 74-85. (doi:10.1016/j.surg.2007.03.001)
28. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM et al. 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Annals of Surgery 222 339-352. (doi:10.1097/00000658-199509000-00011)
29. Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J, Bonab AA, Fischman AJ, Yarmush ML&Stylopoulos N 2013 Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 341 406-410. (doi:10.1126/science.1235103)
30. Saillan-Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, Guy-Crotte O, Escrieut C, Vaysse N, Gomis R et al. 1999 Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 48 2015-2021. (doi:10.2337/diabetes.48.10.2015)
31. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA&Butler PC 2013 ß-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 36 111-117. (doi:10.2337/dc12-0421)
32. Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F&Mingrone G 2013 Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Annals of Surgery 257 462-468. (doi:10.1097/SLA.0b013e318269cf5c)
33. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R&Luketich J 2000 Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Annals of Surgery 232 515-529. (doi:10.1097/00000658-200010000-00007)
34. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E et al. 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 238 467-484. (doi:10.1097/01.sla.0000089851.41115.1b)
35. Scopinaro N, Gianetta E, Adani GF, Friedman D, Traverso E, Marinari GM, Cuneo S, Vitale B, Ballari F, Colombini M et al. 1996 Biliopancreatic diversion for obesity at eighteen years. Surgery 119 261-268. (doi:10.1016/S0039-6060(96)80111-5)
36. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML & Lloyd RV 2005 Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New England Journal of Medicine 353 249-254. (doi:10.1056/NEJMoa043690)
37. Speck M, Cho YM, Asadi A, Rubino F&Kieffer TJ 2011 Duodenal-jejunal bypass protects GK rats from ß-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. American Journal of Physiology-Endocrinology and Metabolism 300 E923-E932. (doi:10.1152/ajpendo.00422.2010)
38. Talchai C, Xuan S, Lin HV, Sussel L&Accili D 2012 Pancreatic ß cell dedifferentiation as a mechanism of diabetic ß cell failure. Cell 150 1223-1234. (doi:10.1016/j.cell.2012.07.029)
39. Tasyurek HM, Altunbas HA, Balci MK&Sanlioglu S 2014 Incretins: their physiology and application in the treatment of diabetes mellitus. Diabetes Metabolism Research and Reviews 30 354-371. (doi:10.1002/dmrr.2501)
40. Thaler JP&Cummings DE 2009 Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150 2518-2525. (doi:10.1210/en.2009-0367)
41. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M&Portha B 2002 Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the ß-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51 1443-1452. (doi:10.2337/diabetes.51.5.1443)
42. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B et al. 2008 Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metabolism 8 201-211. (doi:10.1016/j.cmet.2008.08.008)
43. Wang Z, York NW, Nichols CG&Remedi MS 2014 Pancreatic ß cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metabolism 19 872-882. (doi:10.1016/j.cmet.2014.03.010)
44. Wittgrove A&Clark G 2000 Laparoscopic gastric bypass. Roux-en-Y 500 patients: technique and results, with 3-60 month follow-up. Obesity Surgery 10 233-239. (doi:10.1381/096089200321643511)
45. Xu G, Kaneto H, Lopez-Avalos M, Weir G&Bonner-Weir S 2006 GLP-1/exendin-4 facilitates ß-cell neogenesis in rat and human pancreatic ducts. Diabetes Research and Clinical Practice 73 107-110. (doi:10.1016/j.diabres.2005.11.007)
46. Zhang R, Yan C, Zhou X, Qian B, Li F, Sun Y, Shi C, Li B, Saito S, Horimoto K et al. 2013 Association of Rev-erba in adipose tissues with Type 2 diabetes mellitus amelioration after gastric bypass surgery in Goto-Kakizaki rats. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 305 R134-R146. (doi:10.1152/ajpregu.00520.2012)